[Elsevier]
The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis
Authors:Nathalie Hennuyer; Isabelle Duplan; Charlotte Paquet; Jonathan Vanhoutte; Eloise Woitrain; Véronique Touche; Sophie Colin; Emmanuelle Vallez; Sophie Lestavel; Philippe Lefebvre; Bart Staels